Loss of p53 function by mutational inactivation is the most common marker of the cancerous phenotype. Previous studies from our laboratory have demonstrated 17 b estradiol (E 2 ) induction of p53 protein expression in breast cancer cells. Although direct eects of E 2 on the expression of p53 gene are not known, the steroid is a potent regulator of c-Myc transcription. In the present studies, we have examined the ability of E 2 and antiestrogens to regulate the P1 promoter of the p53 gene which contains a c-Myc responsive element. Estrogen receptor (ER)-positive T47D and MCF-7 cells were transiently transfected with the P1CAT reporter plasmid and levels of CAT activity in response to serum, E 2 and antiestrogens were monitored. Factors in serum were noted to be the dominant inducers of chloramphenicol acetyltransferase (CAT) expression in MCF-7 cells. The levels of CAT were drastically reduced when cells were maintained in serum free medium (SFM). However, a subtle ER-mediated induction of CAT expression was detectable when MCF-7 cells, cultured in SFM, were treated with E 2 . In serum-stimulated T47D cells, the CAT expression was minimal. The full ER antagonist, ICI 182 780 (ICI) had no eect. Treatment with E 2 or 4-hydroxy tamoxifen (OHT) resulted in P1CAT induction; OHT was more eective than E 2 . Consistent with c-Myc regulation of the P1 promoter, E 2 stimulated endogenous c-Myc in both cell lines. Two forms of c-Myc were expressed independent of E 2 stimuli. The expression of a third more rapidly migrating form was E 2 -dependent and ER-mediated since it was blocked by the full ER antagonist, ICI, but not by the ER agonist/antagonist OHT. These data demonstrate both ER-mediated and ER-independent regulation of c-Myc and the P1 promoter of the p53 gene, and show dierential eects of the two classes of antiestrogens in their ability to induce the P1 promoter of the p53 gene in breast cancer cells.
Introduction
Retinoblastoma protein (pRB), c-Myc, and p53 mediate interconnected signal transduction pathways that determine cell fate (Rustgi et al., 1991; Hamel et al., 1992; Dulic et al., 1994; Hermeking and Eick, 1994 ). Each appears to play a crucial role in apoptosis or programmed cell death, a process thought to be crucial for destroying tumor cells (Evan et al., 1992; Hermeking and Eick, 1994; Lowe et al., 1993 Lowe et al., , 1994 Hass-Kogan et al., 1995) . The proliferative steroid hormone, E 2 has been implicated as an upstream regulator of all three proteins (Hurd et al., 1995 (Hurd et al., , 1997 Dubick and Shiu, 1988; Altucci et al., 1996; Lukas et al., 1996; Foster and Wimalasena, 1996; Planas-Silva and Weinberg, 1997, Prall et al., 1997) , suggesting that E 2 might coordinate their expression in estrogen target tissues.
E 2 action is mediated by the ER, a member of the steroid/thyroid hormone receptor superfamily of ligand inducible transcription factors which regulate gene expression by complexing with cis-responsive elements in the promoters of hormonally regulated genes (Hurd and Moudgil, 1998) . E 2 has been shown to rapidly induce transcription of c-Myc (Dubick and Shiu, 1988) and to increase transcription of the cyclin D1 gene (Altucci et al., 1996) in MCF-7 cells, indicating that ER could mediate both a proliferative pathway via cyclin D1 and an apoptotic pathway through c-Myc at the level of gene transcription.
We had previously demonstrated that a physiological concentration of E 2 is sucient to maintain high level expression of a mutant form of p53 in T47D cells. The induction of p53 by E 2 occurs prior to hyperphosphorylation of pRB and can be blocked by antiestrogens (Hurd et al., 1995 (Hurd et al., , 1997 . This suggested that ER acts as a master switch, regulating both a proliferative pathway (cyclin D1 expression-pRB) and in parallel an anti-proliferative pathway involving induction of p53. Hypothetically, attenuation of the p53 pathway without loss of the proliferative pathway would drastically increase the likelihood of malignant transformation in estrogen target cells. It is thus important to determine precisely how E 2 regulates p53 expression.
The most obvious means of E 2 regulation of p53 would be via direct binding of ER to the p53 promoter. The latter, however, does not appear to contain a consensus ERE, making this possibility unlikely. The P1 region of the p53 promoter contains a c-Myc/Max response element (E-box element) (Roy et al., 1994; Uittenbogaard et al., 1995) and E 2 has been shown to activate transcription of c-Myc early in G1 (Dubik and Shiu, 1988) . We thus considered the possibility that E 2 stimulus of c-Myc might activate the P1 promoter of the p53 gene via its E-box element. To determine this, we transiently transfected the ER-positive MCF-7 and T47D breast cancer cell lines with the P1CAT reporter plasmid which contains a 2.4 kb insert derived from the 5' region of the human p53 gene, inclusive of the E-box element (Roy et al., 1994; Uittenbogaard et al., 1995) , and monitored the CAT expression levels in response to serum, E 2 and antiestrogens. Although it is possible that other factors might also activate p53 gene expression independently of ER, our results demonstrate involvement of c-Myc in ER-mediated and ERindependent regulation of the P1 promoter of the p53 gene in T47D and MCF-7 breast cancer cells.
Results

Eects of E2 and antiestrogens on P1CAT induction
T47D and MCF-7 cells were cultured to 40% con¯uency in medium containing whole serum prior to transfection with P1CAT. One set of cells included the P1CAT reporter plasmid (+P1CAT), another set was treated identically without including the P1CAT plasmid (7P1CAT). Transfectant media was removed and cells were cultured for 48 h in media containing whole serum plus ethanol vehicle, E 2 , ICI or OHT (Figure 1 ). Only cells transfected with the plasmid expressed detectable CAT activity, demonstrating that the assay is not obscured by endogenous eukaryotic acetylases that could be regulated by treatment of the cells with E 2 or the antiestrogens.
In transfected T47D cells 1 nM E 2 and 1 mM OHT increased the level of CAT activity signi®cantly above control levels. In contrast, treatment with the full ER antagonist ICI (1 mM) had no eect on the CAT expression. These results were somewhat unexpected. We had previously shown that p53 protein levels are maximal when T47D cells are cultured in whole serum and do not require addition of exogenous E 2 (Hurd et al., 1995) . However, as Figure 1 shows, the induction of CAT was minimal when cells were cultured in whole serum alone (Figure 1 , vehicle) and exogenous E 2 increases CAT activity. The eect of this low concentration (1 nM) of E 2 suggests an ER mediated mechanism that stimulates p53 gene expression through cis acting elements of the P1 region of the p53 gene. Although OHT has been shown to exert ER-agonistic eects, its super-agonistic action compared to E 2 , suggests that in serum stimulated T47D cells, OHT may have eects entirely independent of ER.
Treatment of transfected MCF-7 cells cultured in media containing whole serum with ER ligands did not appear to signi®cantly change CAT expression ( Figure  1, +P1CAT ), indicating that serum factors stimulate signal transduction pathways that regulate the P1 promoter which are independent of ER mediation. In particular, the inability of ICI, a full ER antagonist, to signi®cantly decrease CAT expression demonstrates a non-ER mediated mechanism.
ER-mediated induction of P1CAT and eects of serum
We considered the possibility that serum factors could be masking a more subtle ER-mediated regulation of P1CAT or that a 1 nM concentration of E 2 was not sucient to induce CAT expression in MCF-7 cells. We analysed the eect of a 20 nM concentration of E 2 and the ability of ICI to block its eect when MCF-7 cells were cultured in minimal growth conditions ( Figure 2 ). Cells were cultured to 40% con¯uency and transfected in SFM for 24 h. Transfection solution was removed and the cells were cultured for 48 h in SFM or media supplemented with whole bovine calf serum (BCS) in the presence of ethanol vehicle (0.2%), 20 nM E 2 or 20 nM E 2 +1 mM ICI. Figure 2 clearly shows that serum is the major factor stimulating CAT expression in MCF-7 cells (compare vehicle controls for SFM and BCS). However, when MCF-7 cells are cultured in SFM, increased CAT activity was clearly detectable when cells were treated with 20 nM E 2 . A competitive concentration of ICI combined with E 2 blocked the E 2 eect and reduced CAT expression to control levels, indicating an ERmediated mechanism. Thus, although serum factors maximally stimulate the P1 promoter in MCF-7 cells, a subtle eect which appears to be ER-mediated can be discerned in the absence of background serum eects.
Exogenous E 2 restores maximal CAT expression in cells cultured in steroid-depleted serum Endogenous steroids contained in whole serum can be removed by treating it with charcoal-dextran. We examined the contribution of E 2 as distinct from other steroid hormones that may be present in whole serum on serum stimulation of P1CAT (Figure 3 ). MCF-7 cells were transiently transfected in SFM as before and then treated with media containing whole BCS (whole), serum depleted of endogenous steroids by charcoal-
+P1CAT
-P1CAT Figure 1 Eects of E 2 and antiestrogens on P1CAT induction. T47D or MCF7 cells were cultured in 60 mm plates to 40% con¯uency in medium containing 5% whole FBS (T47D) or 5% whole BCS serum (MCF-7). One set of each cell type was transiently transfected 24 h with 6 mg/plate of P1CAT reporter plasmid in 3 ml SFM (+P1CAT). Another set of cells was treated identically without the inclusion of P1CAT (7P1CAT). Transfectant medium was aspirated and the cells were cultured for 48 h in medium containing whole serum plus 0.1% ethanol vehicle, 1 nM E 2 or T47D cells or 20 nM E 2 for MCF-7 cells, 1 mM ICI for 1 mM OHT. Cell extracts were prepared and CAT activity assessed as described in Materials and methods. CAT, chloramphenicol acetyltransferase; E 2 , 17-b estradiol; BCS, bovine calf serum; ICI, ICI 182 780; OHT, 4-hydroxy tamoxifen; SFM, serum free medium dextran stripping (stripped) or in stripped serum supplemented with 20 nM E 2 . Reduced levels of CAT activity were detected in cells treated with stripped serum, suggesting that steroids may be components of whole serum required for maximal induction of P1CAT in MCF-7 cells. Supplementation of stripped serum with exogenous E 2 resulted in restoration of maximal CAT activity as observed when cells are treated with whole serum. This demonstrates that E 2 is sucient to replace serum factors removed by stripping that are required for maximal stimulation of P1CAT in MCF-7 cells.
Induction of c-Myc protein expression
Assuming the E 2 -dependent P1CAT expression is directly regulated by c-Myc, the endogenous levels of the protein should be sensitive to E 2 and antiestrogens. We thus analysed the expression levels of endogenous c-Myc in response to E 2 and antiestrogens in T47D and MCF-7 cells. The cells were cultured in medium containing steroid-depleted serum for six days to withdraw them from E 2 stimulus and then treated with E 2 alone or in combination with antiestrogens. MCF-7 cells were cultured in medium containing whole BCS to 40% con¯uency in 60 mm plates and then transiently transfected 24 h with 5 mg P1CAT reporter plasmid/plate of cells in 2.5 ml SFM. Transfectant media was removed and cells were cultured for 48 h in SFM or media containing whole BCS supplemented with 20 nM E 2 , 20 nM E 2 +1 mM ICI (E 2 +ICI) or with ethanol vehicle (0.2%). Cell extracts were prepared and CAT activity assessed as described in Materials and methods. CAT, chloramphenicol acetyltransferase; E 2 17-b estradiol; BCS, bovine calf serum; ICI, ICI 182 780; OHT, 4-hydroxy tamoxifen; SFM, serum free medium Figure 3 Exogenous E 2 restores maximal CAT expression when cells are cultured in steroid-depleted serum. MCF-7 cells were cultured in media containing whole BCS to 40% con¯uency in 60 mm plates and then transiently transfected 24 h with 5 mg P1CAT reporter plasmid/plate of cells in 2.5 ml SFM. Transfectant medium was removed and cells were cultured for 24 h in medium containing BCS (whole), medium containing BCS stripped of endogenous steroids by charcoal-dextran treatment (stripped), or the same supplemented with 20 nM E 2 (stripped+E 2 ). Cell extracts were prepared and CAT activity assessed as described in Materials and methods. CAT, chloramphenicol acetyltransferase; E 2 , 17-b estradiol; BCS, bovine calf serum; SFM, serum free medium to block E 2 induction of the fastest migrating form of c-Myc. The data are thus consistent with E 2 induction of c-Myc, which in turn regulates P1CAT in MCF-7 cells.
Discussion
T47D and MCF-7 cells represent ER-positive breast carcinoma cell lines. Our results demonstrate the ability of ER ligands to regulate P1CAT in both T47D and MCF-7 cells although dierences between the two cell lines were apparent. It is clear that factors in serum that do not require ER mediation activate P1CAT expression maximally in MCF-7 cells. If ER were required, we would expect that ICI, a full ER antagonist would block induction of serum factor stimulation of P1CAT. However this did not occur. The P1CAT reporter plasmid carries a large (2.4 kb) insert derived from the 5' regulatory region of the human p53 gene, only a small segment of which is the Myc/Max responsive element (Roy et al., 1994; Uittenbogaard et al., 1995) . Given the numerous proliferative pathways stimulated by serum, it is not surprising that non-ER mediating factors enhanced CAT expression in MCF-7 cells. Upon serum removal, the induction of P1CAT was drastically reduced. However, an apparent subtle but detectable induction occurred upon treatment of MCF-7 cells with E 2 . Reversal of this eect by ICI indicates an ERmediated mechanism under minimal growth conditions for induction of P1CAT in MCF-7 cells. Removal of endogenous steroids from serum resulted in less than maximal expression which could be restored by E 2 , demonstrating the suciency of E 2 combined with nonsteroid factors for maximal induction of P1CAT in the MCF-7 cell line. Our data suggest that the more slowly migrating forms of c-Myc can mediate CAT expression in the absence of E 2 (stripped serum) and the faster migrating E 2 inducible form enhances CAT expression via c-Myc induction of the E-box element of P1CAT. Alternatively maximal expression of P1CAT could be regulated by the basic helix ± loop ± helix protein USF which has also been shown to induce P1CAT via the Ebox element (Uittenbogaard et al., 1995) or regulation could be entirely independent of the E-box element. In the mouse promoter of p53, nuclear factor ± KB (NFkB) and p53 responsive elements have been identi®ed (Donehower and Bradley, 1993) and p53 has been shown to regulate its own transcription (Dee et al., 1993) . NF-kB mediated activation of the p53 promoter is stimulated by tumor necrosis factor-a, which may be a pathway for arresting cells during stress (Wu and Lozano, 1994) . A site conserved between the mouse and human P1 promoter (PF1-binding site) appears to be responsive to serum (Donehower and Bradley, 1993) and thus a potential cis-element for the eects of serum we have observed in MCF-7 cells. Although a physiological concentration of E 2 stimulates P1CAT in T47D cells, suggesting an ERmediated mechanism, maximal induction of P1CAT was observed when the cells were treated with 1 mM OHT during serum stimulation of the cells (whole serum). This super-agonistic activation of P1CAT by OHT suggests an ER-independent mechanism by OHT in this cell line. Consistent with this possi-bility, tamoxifen treatment of ER-negative MDA-231 cells has been shown to induce apoptosis which appears to be mediated by c-myc (Kang et al., 1996) . It is possible that other potential factors are capable of activation of the P1 promoter in addition to or independent of E 2 or c-Myc. Because of observed signi®cant E 2 -independent activation, the non-E 2 -mediated activation may represent important molecular events.
Direct induction of the p53 gene by c-Myc through its E-box element has been demonstrated using transient cotransfection of c-Myc expression plasmid and the P1CAT reporter (Roy et al., 1994; Uittenbogaard et al., 1995) . Recent in vivo evidence also indicates a role for cMyc in stimulating expression of p53 in mouse mammary cells: unmutated p53 was strongly expressed Eects of antiestrogens. MCF-7 and T47D cells were cultured to con¯uency for six days in medium containing serum depleted of endogenous steroids. Cells were then treated for 6 h with 1 nM E 2 , 1 nM E 2 +100 nM OHT, or 1 nM E 2 +1 mM ICI. Proteins were extracted in high salt buer (0.45 M ionic strength) containing protease and phosphatase inhibitors, resolved by SDS ± PAGE and transferred to a PVDF protein blotting membrane. The membrane was probed with anti-human c-Myc anity puri®ed rabbit polyclonal IgG primary antibody (Upstate Biotechnology Incorporated) and horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody. Bands were visualized by ECL in premalignant mammary glands and in mammary tumors from transgenic mice which overexpress c-Myc (McCormack et al., 1998) . Furthermore, a very rapid and direct induction of the c-Myc gene (5 ± 20 min) in response to E 2 treatment of tamoxifen arrested MCF-7 cells (Dubik and Shiu, 1988) , indicates that c-Myc is a proximal down stream eector of ER-mediated signal transduction. The presence of a c-Myc response element in the P1CAT reporter suggests a potential mechanism involving trans-gene induction of c-Myc by E 2 which enhances p53 gene expression through the E-box element of P1CAT. Our results are consistent with this hypothesis but con®rmation of this mechanism would require further de®nition and characterization of the limited region of the p53 gene that confers responsiveness to E 2 .
Materials and methods
Materials
The P1CAT reporter plasmid was provided by David Reisman (University of South Carolina). P1CAT contains a 2.4-kbp fragment from the human p53 gene promoter (Reisman et al., 1988) . This fragment contains a single Ebox element (CATGTG) at position 729 to 734 relative to the major transcription start site of the p53 gene (Roy et al., 1994) . MCF-7 and T47D cells were obtained from the American Type Culture Collection (ATCC). The antiestrogen, OHT was purchased from Research Biochemicals International (Natick, MA, USA). The antiestrogen, ICI, was a gift from Dr AE Wakeling, Zeneca Pharmaceuticals (Cheshire, England). Chloramphenicol D-threo [dichloroacetyl-1,2
14 C]-CAT assay grade was purchased from DuPont NEN (NEN Life Sciences Products, Boston, MA, USA). Cell culturing reagents were purchased from Sigma.
Cell culture
MCF-7 cells were routinely cultured in Eagles modi®ed minimal essential medium (Sigma M4144) supplemented with sodium pyruvate (110 mg/l), L-glutamine (300 mg/l), sodium bicarbonate (2.2 g/l) and gentamicin (50 mg/ml) and 5% de®ned bovine calf serum (Hyclone SH30072). Culturing of T47D cells and charcoal-dextran stripping of serum have been previously described (Kodali et al., 1994) .
Transient transfection, cell treatment and CAT assay MCF-7 or T47D cells were passaged in media supplemented with whole serum and cultured to 40% con¯uency in 60 mm plates prior to transfection. Cells were transfected for 24 h by the lipofectin method according to instructions from Gibco BRL in SFM containing 1 ± 2 mg of P1CAT/ml of SFM in a total volume of 3 ml SFM/plate. Transfectant was aspirated and the cells were cultured for 48 h in SFM, or in medium containing whole or stripped serum during treatment with ER ligands. ER ligands were prepared to a 1000-fold molar excess in ethanol and added (ml ligand/ml medium) directly to medium (0.1% ethanol vehicle). In experiments where ligands were added in combination the ethanol concentration was 0.2%. Cells were washed 26 with 2 ml phosphate buered saline (PBS), scraped into 1 ml of 40 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.4 and pelleted by microfuge for 5 s at 14 000 r.p.m. Cells were resuspended in 100 ml of 250 mM Tris-HCl, pH 7.8 and burst in liquid nitrogen by the freeze/thaw method. Burst cells were microfuged 14 000 r.p.m. for 10 min at 48C, the supernatant (cell extract) collected and incubated 10 min at 658C to inactivate eukaryotic acetylases. Protein concentration of the cell extracts was determined using the Bio Rad protein assay kit. Reactions contained 25 mg of total protein, 0.05 mCi [
14 C]chloramphenicol (chloramphenicol D-threo [dichloroacetyl-1,2
14 C]), and 0.5 mM Acetyl CoA in a ®nal volume of 50 ml. Reactions were continued for 2 h at 378C. Chloramphenicol was extracted in 0.4 ml ethyl acetate, concentrated by vacuum centrifugation and redissolved in 25 ml ethyl acetate, spotted onto TLC plates and developed for 1.5 h in 95% chloroform/5% methanol. TLC plates were dried and exposed to X-ray ®lm.
Western blot analysis
Protein extraction, SDS ± PAGE and Western blot were performed as previously described (Hurd et al., 1995) , but with the following changes. Denatured protein extracts were resolved on a 10% denaturing polyacrylamide gel. After transfer of the proteins, the polyvinylidene¯uoride (PVDF) membrane was probed with anity puri®ed antihuman c-myc rabbit polyclonal IgG primary antibody (Upstate Biotechnology Incorporated) and horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody (Boehringer ± Mannheim). Bands were visualized by enhanced chemiluminescence method.
Abbreviations BCS, bovine calf serum; CAT, chlomaphenicol acetyltransferase; E 2 , 17-b estradiol; ECL, enhanced chemiluminescence; ER, estrogen receptor; FBS, fetal bovine serum; ICI, (ICI 182 780); OHT, 4-hydroxy tamoxifen; PVDF, polyvinylidene di¯urode; SFM, serum free medium.
